PDB Short entry for 2WOU HEADER TRANSFERASE 28-JUL-09 2WOU TITLE ALK5 IN COMPLEX WITH 4-((4-((2,6-DIMETHYL-3-PYRIDYL)OXY)-2-PYRIDYL) TITLE 2 AMINO)BENZENESULFONAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TGF-BETA RECEPTOR TYPE-1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, RESIDUES 200-503; COMPND 5 SYNONYM: TRANSFORMING GROWTH FACTOR-BETA RECEPTOR TYPE I, TGF-BETA COMPND 6 RECEPTOR TYPE I, TGF-BETA TYPE I RECEPTOR, TBETAR-I, TGFR-1, COMPND 7 SERINE/THREONINE-PROTEIN KINASE RECEPTOR R4, SKR4, ACTIVIN RECEPTOR- COMPND 8 LIKE KINASE 5, ALK-5; COMPND 9 EC: 2.7.11.30; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 7 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS TRANSFERASE, SERINE/THREONINE-PROTEIN KINASE, ALK, ATP-BINDING, KEYWDS 2 KINASE INHIBITOR, NUCLEOTIDE-BINDING, TGF BETA TYPE I RECEPTOR EXPDTA X-RAY DIFFRACTION AUTHOR J.E.DEBRECZENI,R.A.NORMAN,F.W.GOLDBERG,R.A.WARD,R.FINLAY,S.J.POWELL, AUTHOR 2 N.J.ROBERTS,A.P.DISHINGTON,H.J.GINGELL,K.F.WICKSON,A.L.ROBERTS REVDAT 5 08-MAY-19 2WOU 1 REMARK REVDAT 4 04-APR-18 2WOU 1 REMARK REVDAT 3 23-NOV-11 2WOU 1 AUTHOR JRNL REVDAT 2 13-JUL-11 2WOU 1 VERSN REVDAT 1 22-SEP-09 2WOU 0 JRNL AUTH F.W.GOLDBERG,R.A.WARD,S.J.POWELL,J.E.DEBRECZENI,R.A.NORMAN, JRNL AUTH 2 N.J.ROBERTS,A.P.DISHINGTON,H.J.GINGELL,K.F.WICKSON, JRNL AUTH 3 A.L.ROBERTS JRNL TITL RAPID GENERATION OF A HIGH QUALITY LEAD FOR TRANSFORMING JRNL TITL 2 GROWTH FACTOR-BETA (TGF-BETA) TYPE I RECEPTOR (ALK5). JRNL REF J.MED.CHEM. V. 52 7901 2009 JRNL REFN ISSN 0022-2623 JRNL PMID 19736928 JRNL DOI 10.1021/JM900807W REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0055 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 12761 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.229 REMARK 3 R VALUE (WORKING SET) : 0.226 REMARK 3 FREE R VALUE : 0.302 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 654 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.36 REMARK 3 REFLECTION IN BIN (WORKING SET) : 885 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.60 REMARK 3 BIN R VALUE (WORKING SET) : 0.2110 REMARK 3 BIN FREE R VALUE SET COUNT : 49 REMARK 3 BIN FREE R VALUE : 0.2750 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2339 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 30 REMARK 3 SOLVENT ATOMS : 135 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 25.95 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 17.45 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.74000 REMARK 3 B22 (A**2) : 0.21000 REMARK 3 B33 (A**2) : 1.52000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.515 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.315 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.192 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 16.417 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.922 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.872 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2438 ; 0.009 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 1655 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3299 ; 1.135 ; 1.946 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4002 ; 0.812 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 299 ; 5.851 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 108 ;33.567 ;23.056 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 416 ;13.811 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 20 ;13.719 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 359 ; 0.065 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2751 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 527 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1486 ; 0.674 ; 2.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 612 ; 0.110 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2383 ; 1.146 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 952 ; 0.604 ; 2.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 916 ; 0.971 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 198 A 284 REMARK 3 ORIGIN FOR THE GROUP (A): 8.0242 15.7778 2.9360 REMARK 3 T TENSOR REMARK 3 T11: 0.0261 T22: 0.0831 REMARK 3 T33: 0.0178 T12: 0.0038 REMARK 3 T13: 0.0104 T23: 0.0248 REMARK 3 L TENSOR REMARK 3 L11: 1.9082 L22: 1.2553 REMARK 3 L33: 1.3137 L12: -0.2650 REMARK 3 L13: 0.5427 L23: -0.1624 REMARK 3 S TENSOR REMARK 3 S11: -0.0228 S12: -0.0402 S13: 0.0567 REMARK 3 S21: -0.0250 S22: -0.0069 S23: 0.0034 REMARK 3 S31: 0.0158 S32: -0.0599 S33: 0.0296 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 285 A 500 REMARK 3 ORIGIN FOR THE GROUP (A): 8.9790 -5.0829 16.6135 REMARK 3 T TENSOR REMARK 3 T11: 0.0306 T22: 0.0340 REMARK 3 T33: 0.0660 T12: 0.0127 REMARK 3 T13: 0.0133 T23: 0.0425 REMARK 3 L TENSOR REMARK 3 L11: 1.6731 L22: 1.4983 REMARK 3 L33: 1.9056 L12: 0.3984 REMARK 3 L13: -0.5380 L23: -0.8238 REMARK 3 S TENSOR REMARK 3 S11: -0.0498 S12: -0.0498 S13: -0.1847 REMARK 3 S21: -0.0419 S22: 0.0080 S23: -0.0361 REMARK 3 S31: 0.1197 S32: 0.0501 S33: 0.0418 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. U VALUES RESIDUAL ONLY. REMARK 4 REMARK 4 2WOU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 28-JUL-09. REMARK 100 THE DEPOSITION ID IS D_1290040589. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-OCT-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : D*TREK REMARK 200 DATA SCALING SOFTWARE : D*TREK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15281 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 24.700 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 3.740 REMARK 200 R MERGE (I) : 0.17000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 4.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.3 REMARK 200 DATA REDUNDANCY IN SHELL : 3.74 REMARK 200 R MERGE FOR SHELL (I) : 0.40000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.36 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.03 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SITTING DROP METHOD. DROPS PROTEIN REMARK 280 -PRECIPITANT 1-1, PROTEIN: 10MG/ML ALK5, PRECIPITANT: 20-30% REMARK 280 PEG8K, 100 MM PCTP BUFFER PH 8.5-9.2, 0.2 M NAAC, VAPOR REMARK 280 DIFFUSION, SITTING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 20.94050 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 45.19350 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.52100 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 45.19350 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 20.94050 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 38.52100 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN A 497 REMARK 465 GLN A 498 REMARK 465 GLU A 499 REMARK 465 GLY A 500 REMARK 465 ILE A 501 REMARK 465 LYS A 502 REMARK 465 MET A 503 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 213 CD CE NZ REMARK 470 LYS A 223 CE NZ REMARK 470 ARG A 240 NE CZ NH1 NH2 REMARK 470 LYS A 343 CG CD CE NZ REMARK 470 ASP A 363 CG OD1 OD2 REMARK 470 ASN A 370 CG OD1 ND2 REMARK 470 HIS A 371 CG ND1 CD2 CE1 NE2 REMARK 470 ASP A 386 CG OD1 OD2 REMARK 470 LYS A 391 CG CD CE NZ REMARK 470 GLU A 439 CG CD OE1 OE2 REMARK 470 ASN A 456 CG OD1 ND2 REMARK 470 LYS A 469 CG CD CE NZ REMARK 470 ARG A 472 CD NE CZ NH1 NH2 REMARK 470 ARG A 487 CD NE CZ NH1 NH2 REMARK 470 LYS A 490 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 201 -92.55 -114.95 REMARK 500 ARG A 332 -3.97 81.95 REMARK 500 ASP A 333 41.72 -147.95 REMARK 500 LYS A 391 31.98 -97.25 REMARK 500 ARG A 457 -39.00 -38.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1497 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZZF A 1500 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1PY5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF TGF-BETA RECEPTOR I KINASE WITHINHIBITOR REMARK 900 RELATED ID: 1IAS RELATED DB: PDB REMARK 900 CYTOPLASMIC DOMAIN OF UNPHOSPHORYLATED TYPE I TGF-BETARECEPTOR REMARK 900 CRYSTALLIZED WITHOUT FKBP12 REMARK 900 RELATED ID: 1B6C RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF THE TYPE I TGF-BETA REMARK 900 RECEPTOR IN COMPLEX WITH FKBP12 REMARK 900 RELATED ID: 1VJY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A NAPHTHYRIDINE INHIBITOR OF HUMAN TGF-BETA REMARK 900 TYPE I RECEPTOR REMARK 900 RELATED ID: 1RW8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF TGF-BETA RECEPTOR I KINASE WITH ATPSITE REMARK 900 INHIBITOR REMARK 900 RELATED ID: 2WOT RELATED DB: PDB REMARK 900 ALK5 IN COMPLEX WITH 4-((5,6-DIMETHYL-2 -(2-PYRIDYL)-3-PYRIDYL)OXY)- REMARK 900 N-(3,4,5- TRIMETHOXYPHENYL)PYRIDIN-2-AMINE REMARK 999 REMARK 999 SEQUENCE REMARK 999 G198 AND G199 ARE CLONING ARTIFACTS. DBREF 2WOU A 198 199 PDB 2WOU 2WOU 198 199 DBREF 2WOU A 200 503 UNP P36897 TGFR1_HUMAN 200 503 SEQRES 1 A 306 GLY GLY THR ILE ALA ARG THR ILE VAL LEU GLN GLU SER SEQRES 2 A 306 ILE GLY LYS GLY ARG PHE GLY GLU VAL TRP ARG GLY LYS SEQRES 3 A 306 TRP ARG GLY GLU GLU VAL ALA VAL LYS ILE PHE SER SER SEQRES 4 A 306 ARG GLU GLU ARG SER TRP PHE ARG GLU ALA GLU ILE TYR SEQRES 5 A 306 GLN THR VAL MET LEU ARG HIS GLU ASN ILE LEU GLY PHE SEQRES 6 A 306 ILE ALA ALA ASP ASN LYS ASP ASN GLY THR TRP THR GLN SEQRES 7 A 306 LEU TRP LEU VAL SER ASP TYR HIS GLU HIS GLY SER LEU SEQRES 8 A 306 PHE ASP TYR LEU ASN ARG TYR THR VAL THR VAL GLU GLY SEQRES 9 A 306 MET ILE LYS LEU ALA LEU SER THR ALA SER GLY LEU ALA SEQRES 10 A 306 HIS LEU HIS MET GLU ILE VAL GLY THR GLN GLY LYS PRO SEQRES 11 A 306 ALA ILE ALA HIS ARG ASP LEU LYS SER LYS ASN ILE LEU SEQRES 12 A 306 VAL LYS LYS ASN GLY THR CYS CYS ILE ALA ASP LEU GLY SEQRES 13 A 306 LEU ALA VAL ARG HIS ASP SER ALA THR ASP THR ILE ASP SEQRES 14 A 306 ILE ALA PRO ASN HIS ARG VAL GLY THR LYS ARG TYR MET SEQRES 15 A 306 ALA PRO GLU VAL LEU ASP ASP SER ILE ASN MET LYS HIS SEQRES 16 A 306 PHE GLU SER PHE LYS ARG ALA ASP ILE TYR ALA MET GLY SEQRES 17 A 306 LEU VAL PHE TRP GLU ILE ALA ARG ARG CYS SER ILE GLY SEQRES 18 A 306 GLY ILE HIS GLU ASP TYR GLN LEU PRO TYR TYR ASP LEU SEQRES 19 A 306 VAL PRO SER ASP PRO SER VAL GLU GLU MET ARG LYS VAL SEQRES 20 A 306 VAL CYS GLU GLN LYS LEU ARG PRO ASN ILE PRO ASN ARG SEQRES 21 A 306 TRP GLN SER CYS GLU ALA LEU ARG VAL MET ALA LYS ILE SEQRES 22 A 306 MET ARG GLU CYS TRP TYR ALA ASN GLY ALA ALA ARG LEU SEQRES 23 A 306 THR ALA LEU ARG ILE LYS LYS THR LEU SER GLN LEU SER SEQRES 24 A 306 GLN GLN GLU GLY ILE LYS MET HET EDO A1497 4 HET ZZF A1500 26 HETNAM EDO 1,2-ETHANEDIOL HETNAM ZZF 4-({4-[(2,6-DIMETHYLPYRIDIN-3-YL)OXY]PYRIDIN-2- HETNAM 2 ZZF YL}AMINO)BENZENESULFONAMIDE HETSYN EDO ETHYLENE GLYCOL FORMUL 2 EDO C2 H6 O2 FORMUL 3 ZZF C18 H18 N4 O3 S FORMUL 4 HOH *135(H2 O) HELIX 1 1 ILE A 201 ARG A 203 5 3 HELIX 2 2 GLU A 238 GLN A 250 1 13 HELIX 3 3 SER A 287 TYR A 295 1 9 HELIX 4 4 MET A 302 SER A 311 1 10 HELIX 5 5 LEU A 313 MET A 318 1 6 HELIX 6 6 THR A 375 MET A 379 5 5 HELIX 7 7 ALA A 380 ASP A 385 1 6 HELIX 8 8 HIS A 392 MET A 404 1 13 HELIX 9 9 LEU A 406 ARG A 413 1 8 HELIX 10 10 SER A 437 CYS A 446 1 10 HELIX 11 11 PRO A 455 SER A 460 5 6 HELIX 12 12 CYS A 461 TRP A 475 1 15 HELIX 13 13 THR A 484 SER A 496 1 13 SHEET 1 AA 5 ILE A 205 SER A 210 0 SHEET 2 AA 5 VAL A 219 TRP A 224 -1 O ARG A 221 N GLN A 208 SHEET 3 AA 5 VAL A 229 SER A 235 -1 O VAL A 231 N TRP A 220 SHEET 4 AA 5 THR A 274 ASP A 281 -1 O LEU A 276 N PHE A 234 SHEET 5 AA 5 ALA A 264 ASP A 269 -1 O ALA A 264 N VAL A 279 SHEET 1 AB 3 ILE A 329 ALA A 330 0 SHEET 2 AB 3 VAL A 356 ASP A 359 -1 O VAL A 356 N ALA A 330 SHEET 3 AB 3 THR A 364 ILE A 365 -1 O THR A 364 N ASP A 359 SHEET 1 AC 2 ILE A 339 VAL A 341 0 SHEET 2 AC 2 CYS A 347 ILE A 349 -1 O CYS A 348 N LEU A 340 SITE 1 AC1 4 MET A 253 ASP A 269 THR A 272 TRP A 273 SITE 1 AC2 17 ILE A 211 VAL A 219 ALA A 230 LEU A 260 SITE 2 AC2 17 LEU A 278 SER A 280 ASP A 281 TYR A 282 SITE 3 AC2 17 HIS A 283 GLY A 286 ASP A 290 GLY A 322 SITE 4 AC2 17 THR A 323 LEU A 340 ASP A 351 HOH A2024 SITE 5 AC2 17 HOH A2135 CRYST1 41.881 77.042 90.387 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023877 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012980 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011064 0.00000